These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11584760)

  • 21. Echinocandins--an advance in the primary treatment of invasive candidiasis.
    Walsh TJ
    N Engl J Med; 2002 Dec; 347(25):2070-2. PubMed ID: 12490691
    [No Abstract]   [Full Text] [Related]  

  • 22. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response and relapse rates of candidal esophagitis in HIV-infected patients treated with caspofungin.
    Dinubile MJ; Lupinacci RJ; Berman RS; Sable CA
    AIDS Res Hum Retroviruses; 2002 Sep; 18(13):903-8. PubMed ID: 12230933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New drug fights invasive fungal infection.
    FDA Consum; 2001; 35(3):5. PubMed ID: 11458553
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of caspofungin and amphotericin B for invasive candidiasis.
    Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
    N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caspofungin in the treatment of oropharyngeal candidiasis.
    Garbino J; Lew D; Hirschel B; Rohner P
    Int J Clin Pract; 2003 Mar; 57(2):143-4. PubMed ID: 12661800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fungal treatment approved.
    AIDS Patient Care STDS; 2001 Apr; 15(4):229. PubMed ID: 11385760
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin.
    Maschmeyer G; Glasmacher A
    Mycoses; 2005 Jul; 48(4):227-34. PubMed ID: 15982202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The echinocandins, first novel class of antifungals in two decades: will they live up to their promise?
    Graybill JR
    Int J Clin Pract; 2001 Nov; 55(9):633-8. PubMed ID: 11770362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacology and clinical use of caspofungin.
    Hope WW; Shoham S; Walsh TJ
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):263-74. PubMed ID: 17428155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate.
    Goodman D; Pamer E; Jakubowski A; Morris C; Sepkowitz K
    Clin Infect Dis; 2002 Aug; 35(3):E35-6. PubMed ID: 12115115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New systemic antifungal drugs: mechanisms of action, drug interactions and side effects].
    Schäfer-Korting M
    Mycoses; 2003; 46 Suppl 1():28-31. PubMed ID: 12955850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Echinocandin antifungals: review and update.
    Morrison VA
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):325-42. PubMed ID: 16597212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model.
    González GM; Tijerina R; Najvar LK; Bocanegra R; Luther M; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1854-9. PubMed ID: 11353637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echinocandin antifungal drugs.
    Denning DW
    Lancet; 2003 Oct; 362(9390):1142-51. PubMed ID: 14550704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
    Walsh TJ; Teppler H; Donowitz GR; Maertens JA; Baden LR; Dmoszynska A; Cornely OA; Bourque MR; Lupinacci RJ; Sable CA; dePauw BE
    N Engl J Med; 2004 Sep; 351(14):1391-402. PubMed ID: 15459300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients.
    Kulemann V; Bauer M; Graninger W; Joukhadar C
    Pharmacology; 2005 Dec; 75(4):165-78. PubMed ID: 16192747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The echinocandins.
    Cappelletty D; Eiselstein-McKitrick K
    Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.
    Ullmann AJ
    Curr Med Res Opin; 2003; 19(4):263-71. PubMed ID: 12841918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
    del Castillo M; Wainsztein N; Klein F; Manganello S; Orellana N
    Medicina (B Aires); 2004; 64(2):152-4. PubMed ID: 15628305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.